Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ivonne, Archibeque"'
Autor:
Xin, Luo, Ivonne, Archibeque, Ken, Dellamaggiore, Kate, Smither, Oliver, Homann, James Russell, Lipford, Dane, Mohl
Publikováno v:
iScience. 25:103985
The success of small molecule therapeutics that promotes degradation of critical cancer targets has fueled an intense effort to mimic this activity with bispecific molecules called PROTACs (proteolysis targeting chimeras). The simultaneous binding of
Autor:
Yu Li, Victor J. Cee, Pragathi Achanta, Aaron S. Rapaport, Brian A. Lanman, Hui-Ling Wang, Tao Osgood, Karen Rex, Deanna Mohn, Christopher Mohr, Andres Plata Stapper, Jude Canon, J. Russell Lipford, Anne Y. Saiki, Ivonne Archibeque
Publikováno v:
Cancer Research. 81:1285-1285
Sotorasib (formerly known as AMG 510), the first-in-class KRASG12C inhibitor, has demonstrated promising clinical efficacy in KRAS p.G12C mutant cancers. Sotorasib binds to KRASG12C through a unique interaction with a surface groove created by side-c
Autor:
Ivonne Archibeque, Steven G. Elliott, Scott Powers, Paul D. Kassner, Leigh Busse, J E V Watson, Norma Rogers, W Brown, Angus M. Sinclair, G E Arnold, Ken C. Q. Nguyen
Publikováno v:
British Journal of Cancer
Erythropoietin receptor (EpoR) has been reported to be overexpressed in tumours and has raised safety concerns regarding the use of erythropoiesis-stimulating agents (ESAs) to treat anaemia in cancer patients. To investigate the potential for EpoR to
Publikováno v:
Journal of biomolecular screening. 20(4)
The Bispecific T-cell Engager (BiTE) antibody modality is a clinically validated immunotherapeutic approach for targeting tumors. Using T-cell dependent cellular cytotoxicity (TDCC) assays, we measure the percentage of specific cytotoxicity induced w
Autor:
Bee-Chun Sun, Renee Emkey, Ivonne Archibeque, Laurie B. Schenkel, Liqin Liu, Josie Han Lee, Violeta Yu, Stephanie D. Geuns-Meyer, Jeanne Pistillo
Publikováno v:
Experimental hematology. 41(5)
Small molecule inhibitors of Janus kinase (JAK) family members (JAK1, JAK2, JAK3, and Tyk2) are currently being pursued as potential new modes of therapy for a variety of diseases, including the inhibition of JAK2 for the treatment of myeloproliferat
Optimization and utilization of the SureFire phospho-STAT5 assay for a cell-based screening campaign
Autor:
Cherylene Plewa, Angus M. Sinclair, Christina Binder, Ivonne Archibeque, Yu Sun, Renee Emkey, Amy Lafayette
Publikováno v:
Assay and drug development technologies. 6(1)
The family of signal transducers and activators of transcription (STATs) consists of seven transcription factors that respond to a variety of cytokines, hormones, and growth factors. STATs are activated by tyrosine phosphorylation, which results in t
Autor:
Ivonne Archibeque, Linslee M. Luke, S. Thomas Carmichael, Tim Nolan, Songlin Li, Janneth P. Momiy
Publikováno v:
Experimental neurology. 193(2)
Stroke induces axonal sprouting in peri-infarct cortex. A set of growth-associated genes important in axonal sprouting in peripheral nervous system regeneration and cortical development has recently been defined. The expression profiles of these grow
Autor:
Bethany Mattson, Ling Wang, Rachael L. Brake, Ali-Samer Al-Assaad, Gary Means, Ivonne Archibeque, Liqin Liu, Leigh Busse, Kirk Henne, Tim Cushing, Angus M. Sinclair, Graham Molineux, Charlie Starnes, Daniela Metz, Allison Drew
Publikováno v:
Blood. 118:4964-4964
Abstract 4964 Immune receptors such as the B cell receptor (BCR) require key signaling intermediate phosphatidylinositol-3 kinase delta (PI3Kδ) for normal immune cell survival, development and function. PI3Kδ is a class IA lipid kinase, is expresse
Autor:
Ivonne Archibeque, Angus M. Sinclair, Ling Wang, Liqin Liu, Bee-Chun Sun, Marc Payton, Jeanne Pistillo, Graham Molineux
Publikováno v:
Blood. 118:4963-4963
Abstract 4963 Phosphatidylinositol-3 kinase delta (PI3Kδ) is a class IA lipid kinase expressed primarily in leukocytes and is a key signaling molecule for immune receptors such as the B cell receptor (BCR). Dysregulated BCR-PI3Kδ signaling has been
Autor:
Violeta Yu, Graham Molineux, Laurie B. Schenkel, Josie Lee, Liqin Liu, Jeanne Pistillo, Stephanie D. Geuns-Meyer, Renee Emkey, Angus M. Sinclair, Ivonne Archibeque
Publikováno v:
Blood. 118:5150-5150
Abstract 5150 Essential thrombocythemia (ET), polycythemia vera (PV) and myelofibrosis (MF) are myeloproliferative disorders (MPDs) characterized by a chronic over-production of cells of one or more blood cell lineages and/or bone marrow fibrosis whi